These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9589816

  • 1. Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group.
    Tack KJ, Littlejohn TW, Mailloux G, Wolf MM, Keyserling CH.
    Clin Ther; 1998; 20(2):244-56. PubMed ID: 9589816
    [Abstract] [Full Text] [Related]

  • 2. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA, Elston D, Akinlade BK, Weber K, Notario GF, Busman TA, Cifaldi M, Nilius AM.
    Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
    [Abstract] [Full Text] [Related]

  • 3. Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. The Cefdinir Pediatric Skin Infection Study Group.
    Tack KJ, Keyserling CH, McCarty J, Hedrick JA.
    Antimicrob Agents Chemother; 1997 Apr; 41(4):739-42. PubMed ID: 9087480
    [Abstract] [Full Text] [Related]

  • 4. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection.
    Leigh AP, Nemeth MA, Keyserling CH, Hotary LH, Tack KJ.
    Clin Ther; 2000 Jul; 22(7):818-25. PubMed ID: 10945508
    [Abstract] [Full Text] [Related]

  • 5. Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections.
    Bucko AD, Hunt BJ, Kidd SL, Hom R.
    Clin Ther; 2002 Jul; 24(7):1134-47. PubMed ID: 12182257
    [Abstract] [Full Text] [Related]

  • 6. Clinical comparison of cefuroxime axetil, cephalexin and cefadroxil in the treatment of patients with primary infections of the skin or skin structures.
    Gooch WM, Kaminester L, Cole GW, Binder R, Morman MR, Swinehart JM, Wisniewski M, Yilmaz HM, Collins JJ.
    Dermatologica; 1991 Jul; 183(1):36-43. PubMed ID: 1769413
    [Abstract] [Full Text] [Related]

  • 7. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
    Henry DC, Kapral D, Busman TA, Paris MM.
    Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
    [Abstract] [Full Text] [Related]

  • 8. Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis. Cefdinir Pharyngitis Study Group.
    Nemeth MA, McCarty J, Gooch WM, Henry D, Keyserling CH, Tack KJ.
    Clin Ther; 1999 Nov; 21(11):1873-81. PubMed ID: 10890259
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of cefdinir in the treatment of patients with acute bronchitis. The Cefdinir Bronchitis Study Group.
    Sperling MJ, Puopolo A, Griffin TJ, Keyserling CH, Tack KJ.
    Clin Ther; 1996 Nov; 18(4):626-34. PubMed ID: 8879891
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group.
    Gwaltney JM, Savolainen S, Rivas P, Schenk P, Scheld WM, Sydnor A, Keyserling C, Leigh A, Tack KJ.
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1517-20. PubMed ID: 9210677
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
    Lipsky BA, Miller B, Schwartz R, Henry DC, Nolan T, McCabe A, Magner DJ, Talbot GH.
    Clin Ther; 1999 Apr; 21(4):675-90. PubMed ID: 10363733
    [Abstract] [Full Text] [Related]

  • 16. Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.
    Drehobl M, Bianchi P, Keyserling CH, Tack KJ, Griffin TJ.
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1579-83. PubMed ID: 9210689
    [Abstract] [Full Text] [Related]

  • 17. Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections.
    Parish LC, Routh HB, Miskin B, Fidelholtz J, Werschler P, Heyd A, Haverstock D, Church D.
    Int J Clin Pract; 2000 Oct; 54(8):497-503. PubMed ID: 11198726
    [Abstract] [Full Text] [Related]

  • 18. Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis.
    Fogarty CM, Bettis RB, Griffin TJ, Keyserling CH, Nemeth MA, Tack KJ.
    J Antimicrob Chemother; 2000 Jun; 45(6):851-8. PubMed ID: 10837440
    [Abstract] [Full Text] [Related]

  • 19. A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study.
    Block SL, Cifaldi M, Gu Y, Paris MM.
    Clin Ther; 2005 Jun; 27(6):786-94. PubMed ID: 16117986
    [Abstract] [Full Text] [Related]

  • 20. Ofloxacin versus cephalexin in the treatment of skin, skin structure, and soft-tissue infections in adults.
    Powers RD, Schwartz R, Snow RM, Yarbrough DR.
    Clin Ther; 1991 Jun; 13(6):727-36. PubMed ID: 1790547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.